| Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease CA McLean, RA Cherny, FW Fraser, SJ Fuller, MJ Smith, K Vbeyreuther, ... Annals of neurology 46 (6), 860-866, 1999 | 2422 | 1999 |
| The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth EA Milward, R Papadopoulos, SJ Fuller, RD Moir, D Small, K Beyreuther, ... Neuron 9 (1), 129-137, 1992 | 603 | 1992 |
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease IJ Martins, E Hone, JK Foster, SI Sünram-Lea, A Gnjec, SJ Fuller, D Nolan, ... Molecular psychiatry 11 (8), 721-736, 2006 | 464 | 2006 |
| The amyloid precursor protein of Alzheimer's disease is released by human platelets. AI Bush, RN Martins, B Rumble, R Moir, S Fuller, E Milward, J Currie, ... Journal of Biological Chemistry 265 (26), 15977-15983, 1990 | 403 | 1990 |
| The role of type 2 diabetes in neurodegeneration G Verdile, SJ Fuller, RN Martins Neurobiology of disease 84, 22-38, 2015 | 268 | 2015 |
| Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease IJ Martins, T Berger, MJ Sharman, G Verdile, SJ Fuller, RN Martins Journal of neurochemistry 111 (6), 1275-1308, 2009 | 255 | 2009 |
| The role of beta amyloid in Alzheimer’s disease: still a cause of everything or the only one who got caught? G Verdile, S Fuller, CS Atwood, SM Laws, SE Gandy, RN Martins Pharmacological Research 50 (4), 397-409, 2004 | 255 | 2004 |
| Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons JM Gunnersen, MH Kim, SJ Fuller, M De Silva, JM Britto, VE Hammond, ... Neuron 56 (4), 621-639, 2007 | 154 | 2007 |
| Intracellular Production of. beta. A4 Amyloid of Alzheimer's Disease: Modulation by Phosphoramidon and Lack of Coupling to the Secretion of the Amyloid Precursor Protein SJ Fuller, E Storey, QX Li, AI Smith, K Beyreuther, CL Masters Biochemistry 34 (25), 8091-8098, 1995 | 112 | 1995 |
| The amyloid precursor protein of Alzheimer disease in human brain and blood QX Li, SJ Fuller, K Beyreuther, CL Masters Journal of leukocyte biology 66 (4), 567-574, 1999 | 111 | 1999 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 104 | 2018 |
| A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease DH Small, RD Moir, SJ Fuller, S Michaelson, AI Bush, QX Li, E Milward, ... Biochemistry 30 (44), 10795-10799, 1991 | 92 | 1991 |
| Review Genetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease G Veurink, SJ Fuller, CS Atwood, RN Martins Annals of human biology 30 (6), 639-667, 2003 | 68 | 2003 |
| Reproductive hormones modulate oxidative stress in Alzheimer's disease AM Barron, SJ Fuller, G Verdile, RN Martins Antioxidants & redox signaling 8 (11-12), 2047-2059, 2006 | 63 | 2006 |
| Nedd4-WW domain-binding protein 5 (Ndfip1) is associated with neuronal survival after acute cortical brain injury Q Sang, MH Kim, S Kumar, N Bye, MC Morganti-Kossman, J Gunnersen, ... Journal of Neuroscience 26 (27), 7234-7244, 2006 | 59 | 2006 |
| Gelatinase A possesses a β-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease RN LePage, AJ Fosang, SJ Fuller, G Murphy, G Evin, K Beyreuther, ... FEBS letters 377 (2), 267-270, 1995 | 59 | 1995 |
| Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions SJ Fuller, RS Tan, RN Martins Journal of Alzheimer's Disease 12 (2), 129-142, 2007 | 58 | 2007 |
| Distinct distribution of GLUT4 and insulin regulated aminopeptidase in the mouse kidney AL Albiston, HR Yeatman, V Pham, SJ Fuller, S Diwakarla, RN Fernando, ... Regulatory peptides 166 (1-3), 83-89, 2011 | 35 | 2011 |
| Generation of a recombinant Fab antibody reactive with the Alzheimer's disease‐related Aβ peptide AH Tammer, G Coia, R Cappai, S Fuller, CL Masters, P Hudson, ... Clinical & Experimental Immunology 129 (3), 453-463, 2002 | 27 | 2002 |
| Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults P Chatterjee, YJ Cheong, A Bhatnagar, K Goozee, Y Wu, M McKay, ... Journal of Neurochemistry, 2020 | 23 | 2020 |
